PETX - Aratana Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5252.85M
Enterprise Value 3219.85M
Trailing P/E N/A
Forward P/E 151.60
PEG Ratio (5 yr expected) 1-0.87
Price/Sales (ttm)6.53
Price/Book (mrq)2.59
Enterprise Value/Revenue 35.68
Enterprise Value/EBITDA 6-21.95

Trading Information

Stock Price History

Beta (3Y Monthly) -0.07
52-Week Change 324.23%
S&P500 52-Week Change 38.07%
52 Week High 37.16
52 Week Low 33.30
50-Day Moving Average 34.83
200-Day Moving Average 34.57

Share Statistics

Avg Vol (3 month) 3954.13k
Avg Vol (10 day) 3574.94k
Shares Outstanding 549M
Float 40.1M
% Held by Insiders 13.31%
% Held by Institutions 171.89%
Shares Short (Jun 14, 2019) 4729.37k
Short Ratio (Jun 14, 2019) 41.64
Short % of Float (Jun 14, 2019) 41.81%
Short % of Shares Outstanding (Jun 14, 2019) 41.49%
Shares Short (prior month May 15, 2019) 4578.5k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -33.47%
Operating Margin (ttm)-28.45%

Management Effectiveness

Return on Assets (ttm)-5.75%
Return on Equity (ttm)-13.51%

Income Statement

Revenue (ttm)38.73M
Revenue Per Share (ttm)0.82
Quarterly Revenue Growth (yoy)82.00%
Gross Profit (ttm)24.76M
EBITDA -10.02M
Net Income Avi to Common (ttm)-12.96M
Diluted EPS (ttm)-0.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.06M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)796k
Total Debt/Equity (mrq)0.83
Current Ratio (mrq)6.66
Book Value Per Share (mrq)1.99

Cash Flow Statement

Operating Cash Flow (ttm)-3.54M
Levered Free Cash Flow (ttm)1.85M